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1066-189 Elevation of Plasma Adrenomedullin Level Is Closely 
Related to C-Reactive Protein and Interleukin-6 in 
Patients With Peripheral Arterial Occlusive Disease
Yoshihiko Suzuki, Takeshi Horio, Tanenao Eto, Kenji Kangawa, Yuhei Kawano, Miyazaki 
Medical College, Miyazaki, Japan
Background: Adrenomedullin (AM) is known to have anti-atherosclerotic and anti-
inflammatory effects. Although previous studies have shown that plasma AM levels are
elevated in various diseases, there are no data about its level in patients with peripheral
arterial occlusive disease (PAOD), one of severe atherosclerotic diseases. Methods and
Results: We examined 33 patients with PAOD and 39 patients without PAOD. Between
the two groups, there was no significant difference in clinical and laboratory parameters
except serum creatinine and ankle brachial index (ABI). The plasma AM concentration in
PAOD group was significantly higher than in non-PAOD group (11.5 ± 3.0 vs. 9.5 ± 2.2
fmol/mL, p<0.01). Its level had a correlation with the severity of PAOD, i.e., with ABI (r=-
0.39, p<0.01) and Fontaine classification (r=0.32, p<0.01). Furthermore, plasma AM was
significantly correlated with C-reactive protein and interleukin-6 (figure). By multiple
regression analysis, ABI and IL-6 were independent determinants of the plasma level of
AM. Conclusions: The plasma AM concentration was elevated in patients with PAOD in
proportion to the severity. The AM level was also associated with CRP and IL-6, markers
of inflammation. Recent studies showed that elevation of inflammatory parameters, such
as CRP and IL-6, was strongly related to future cardiovascular events. Therefore, an
increased production of AM in patients with PAOD may play a protective role against
advanced atherosclerosis with inflammatory signature.
1066-190 Influence of Statin Therapy on Arterial Elasticity in 
Essential Hypertension
Malgorzata Kurpesa, Zbigniew Bednarkiewicz, Maria Krzeminska-Pakula, Medical 
University, Lodz, Poland
Background: The vascular remodeling is a common problem in patients (pts) with arterial
hypertension (HA). Statins by influence on migration and proliferation of smooth muscle
cells may inhibit the posthypertensive arterial remodeling. Pulse wave velocity (PWV)
provides an indirect, non-invasive measurement of the mechanical properties of arteries.
The aim of the study was to evaluate the influence of statins on arterial elasticity in HA.
Methods: The study group consisted of 52 pts with essential moderate HA. They were
randomised into Group I (26 pts who received statin) and Group II (26 pts who received
placebo). Groups were comparable according to age, gender, blood pressure values and
treatment of HA. Before and following 6 months of treatment PWV was evaluated using a
computer system COMPLIOR. For automatic measurement of PWV pressure waveforms
were digitized at rate 500 Hz for carotid-femoral distance. 10 healthy volunteers consti-
tuted a control group.
Results: After 6 months similar reduction of BP was observed in both groups. Following 6
months of conventional treatment of HA the PWV was slightly decreased. Addition of sta-
tin caused the significant reduction of PWV. (*p<0.01)
Conclusions: 1. Addition of statin to conventional treatment may improve arterial elasticity
in essential HA.
2. Statins are likely to inhibit posthypertensive arterial remodeling
1066-191 A Phase I Study of Intramuscular Administration of 
Plasmid, Developmentally Regulated Endothelial Cell 
Locus-1 Gene, in Humans With Peripheral Arterial 
Disease
Sanjay Rajagopalan, Jeffrey Snell, Marc Litt, Gary L. Schaer, Ronald Karlsberg, Suheil 
Dohad, Stuart W. Young, Valentis Inc., Burlingame, CA
Background: Developmentally regulated endothelial locus 1( Del-1) is a novel angioma-
trix protein. Preclinical studies using a plasmid expressing Del-1 (VLTS–589) in conjunc-
tion with a poloxamer have demonstrated functional improvements in lower extremity
perfusion and exercise tolerance. The objective of this investigation was to assess the
safety of VLTS-589 in subjects with peripheral arterial disease (PAD).
Methods: Subjects with either intermittent claudication (Rutherford 2 and 3, n=18) or crit-
ical limb ischemia (resting pain, Rutherford 4, n=9) were enrolled in an open-label, dose
escalation, 90 day follow-up study after exclusion of conditions that may preclude angio-
genic growth factor delivery (malignancy, retinopathy etc.). 27 subjects received IM injec-
tions in 1 lower extremity (3 to 84 mg, 7 cohorts, C1-C6b; circumferential [C6a] and
posterior, linear [C6b] pattern of injections).
Results: There were no serious adverse events attributable to VTLS-589; no subjects
required amputation. Transient ecchymosis at the injection site, noted in 4 subjects, was
attributed to the injection procedure. Changes in mean peak walking time (PWT) for sub-
jects able to exercise and Ankle/Brachial Index (ABI) data for the entire cohort is reported
below in Table 1. 
Conclusion: IM delivery of up to 84 mg VLTS-589 is well tolerated. These data sup-
ported a controlled Phase II clinical trial (DELTA-1 or Del-1 for Therapeutic Angiogene-
sis), which is currently in progress.
1066-192 Effect of Enzyme Replacement Therapy on Intima Media 
Thickness and Endothelial Function in Fabry Disease
Remy Chenevard, Jr., David Hurlimann, Jr., Urs Widmer, Sr., Frank Ruschitzka, Sr., 
Georg Noll, Sr., University Hospital Zurich, Zurich, Switzerland
Background: Fabry disease is an inborn lysosomal storage disorder with deposition of
glycosphingolipids in the vascular system including endothelial- and smooth muscle
cells, possibly leading to endothelial dysfunction. We tested the hypothesis whether
enzyme replacement therapy (ERT) with agalsidase would alter vascular function.
Methods: Flow mediated vasodilatation (FMD) of the radial artery was assessed using
high-resolution ultrasound; nitroglycerine (NG) sublingually induced endothelium inde-
pendent vasodilatation. Results are expressed as percent change of diameter from base-
line. Intima-media thickness of the brachial artery (IMT) was calculated with a vessel wall
detection software.
Results: 13 hemizygote and 10 heterozygote patients were compared before and after
0.9 years of ERT to 15 age and risk factors matched healthy subjects. Hemizygote Fabry
patients presented with greater IMT at baseline compared to control and heterozygote
patients (470 ±34 µm vs. 401 ±13 µm and 402 ±10 µm; p=0.029 and p=0.049); FMD in
hemizygote and to a less extent in heterozygote patients tended to be impaired versus
control (5.4 ±0.9% and 6.1 ±0.9% vs. 8.2 ±1.2%; p=0.09 and p=0.19). ERT led to normal-
isation of IMT in hemizygote patients (397 ±12 µm; p=0.05) but had no effect on endothe-
lial function (5.0 ±1.2%; p=0.7). IMT correlated inversely with FMD in the control group
(r2=0.411), but not in Fabry patients (r2<0.01).
Conclusions: One year of ERT reduced IMT in hemizygote patients but had no effect on
endothelial function. Our data suggest that structural changes seen in Fabry disease are
unrelated to functional parameters as typically observed in atherosclerotic vascular dis-
ease.
1066-193 Endovascular Stent-Graft Placement for Nonsurgical 
Repair of Descending Aortic Perforations: Acute and 
Follow-Up Results
Dierk Scheinert, Andrej Schmidt, Susanne Scheinert, Sven Bräunlich, Hans 
Krankenberg, Giancarlo Biamino, Friedrich Mohr, Heart Center Leipzig, Leipzig, 
Germany
Background: Perforating lesions of the descending thoracic aorta are a life-threatening
condition associated with high morbidity and mortality.
Methods: Between January 1999 and October 2002 a total of 25 consecutive patients (15
male, mean age 63.3 years) underwent percutaneous treatment for perforating lesions in
the descending aorta. In 19 cases (group A) the aortic perforation was due to ruptured
aortic type-B dissections (n=13) or rupture of preexisting atherosclerotic thoracic aneu-
rysms (n=6); 6 patients (group B) were treated for posttraumatic perforations of the
descending aorta. In total 31 endoprostheses were implanted (4 patients with two and 1
patient with three endoprostheses).
Results: The implantation of the endoprosthesis was successfully performed in all cases
without periinterventional complications. In one case implantation of a second endopros-
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thesis became necessary due to incomplete coverage of the lesion with subsequent
leakage. Three of the 25 patients died within 30 days, for an early mortality rate of 12%.
As all deaths occured in group A, the mortality rate in this group was 15.8% vs. 0% in
group B. Similarly, postinterventional complications were more prevalent with 31.6% in
group A (renal failure n=4; ischemic stroke n=2) vs. 16.6% in group B (renal failure n=1).
There was no further death or rupture during the average follow-up period of 16 months.
Conclusion: These initial results suggest that percutaneous stent-graft placement offers
an effective nonsurgical treatment option for emergency repair of descending aortic per-
forations. The procedure associated morbidity and mortality is higher for patients with
ruptured dissecting or atherosclerotic thoracic aneurysms.
1066-194 Clinical Outcomes From Patients Treated With 
Endovascular Stent Graft for Thoracic Aortic 
Aneurysms
Satoshi Kawaguchi, Shin Ishimaru, Taro Shimazaki, Yoshihiko Yokoi, Tokyo Medical 
University, Tokyo, Japan
Background : Despite advances in operative technique and management having
improved the clinical outcomes of conventional open surgical replacement for thoracic
aortic aneurysms(TAA) , it remains an invasive procedure especially for aged patients.
Over the past several years, minimally invasive endovascular surgery using a stent
graft(SG), has made significant advances for the treatment of aneurysms. We investi-
gated clinical results of the SG repair for TAA we have experienced up to the present.
Methods : For eight years from 1995, 202 patients of TAA were treated with the endovas-
cular technique using the SG in our hospital. All patients were treated under general
anesthesia and the SGs were implanted with the sheath introducer(20 Fr.) via femoral
arteries under fluoroscopic guidance using our original guiding technique, tug of wire
method. The SG which was composed of several units of self-expanding Z stents cov-
ered with a polyester fabric, was originally and individually designed for each patient.
Results : Exclusion of the aneurysms without endoleak were achieved within two weeks
postoperatively in 179 of 202 patients (initial success rate: 88.6%). Peri-postoperative
early complications included 3 cerebral infarction, 3 paraparesis, 4 injuries to aorta, and
10 injuries to arteries as access routes. Five patients died in a month after operation with
relation of the endovascular repair. In mid-long term following, graft migration was found
in 8 and second endoleak appeared in 10 patients (Type I:8, III:1, IV:1). Ninety patients
possibly underwent the reassessment of aneurysmal size and shape with CT. Reduction
of aneurysmal size was documented in 48 patients (53.3%), and it remained unchanged
in 32 patients (35.6%). Enlargement was detected in 10 patients (11.1%). The survival
ratio in postoperative five years was 62.8%.
Conclusion : A good long-term results and no enlargement of aneurysms are expected in
cases of excluded aneurysms without endoleak. Endovascular stent grafting shows
potential as a safe and useful treatment for thoracic aortic aneurysms, but further investi-
gation should attempt to determine its efficacy over a longer postoperative period.
1066-195 Prevalence of Aortic Intramural Hematoma: A 
Transesophageal Echocardiographic Hospital-Based 
Cohort Study of 2,147 Subjects
Thomas Buck, Mariam Kabir, Michael Rauwolf, Andreas Stang, Holger Eggebrecht, Karl 
Heinz Joeckel, Raimund Erbel, University Essen, Essen, Germany
Background: Aortic intramural hematoma (IMH) has been assumed to precede aortic
dissection, a life-threatening event. While the prevalence of IMH in patients with acute
aortic syndrome was found to be in the range of 10-30%, uncertainty exists regarding the
prevalence of IMH in the general population compared to a population with know cardio-
vascular (CV) disease.
Methods: In a hospital-based cohort study 2147 individual patients were examined by
standardized transesophageal echocardiography (TEE) including systematic assess-
ment of the thoracic aorta. 1045 patients (48.7%) (age 54±14yrs, 620 male, 425 female)
were exclusively referred for exclusion of source of embolism without known or sus-
pected CV diseases, therefore considered of representing a sample of the general popu-
lation at common CV risk. 1102 patients (51.3%) (age 63±15yrs, 631 male, 471 female)
had known CV diseases including hypertension. IMH was defined as circular or crescent
wall thickening greater than 0.5 cm with or without echo free spaces, calcium deposits,
and multiple layering but without signs of flow indicating an intimal tear or subtle dissec-
tion. Patient data, history, CV risk factors, systematic TEE images of the thoracic aorta
and measurements were archived digitally in a custom-made database for statistical
analysis.
Results: In the general population group we found no prevalence (0%) of IMH with 0 of
1045 subjects with signs of IMH compared to a significantly higher prevalence of 2.0%
(p<.001) in the CV disease group with 22 of 1102 patients with IMH. Aortic dissection
(AD) was found only in 3 subjects of the general population group (prevalence 0.3%)
compared to 41 in the CV disease group (prevalence 3.7%, p<.001).
Conclusions: The prevalence of 0% for IMH in the general population group compared
to 2% in the CV risk group establishes for the first time a close relation of IMH with the
presence of CV diseases. Because aortic dissection was also significantly more preva-
lent in the CV disease group patients with IMH may be monitored carefully and risk
reduction started.
1066-196 Erectile Dysfunction of Vascular Origin Is Associated 
With Generalized Endothelial Dysfunction
Marc R. Pritzker, Rhonda Groebner, Minneapolis Heart Institute Foundation, 
Minneapolis, MN
Previous work has linked the presence of brachial artery endothelial dysfunction with
subsequent coronary events.Erectile dysfunction (ED) is a localized form of endothelial
dysfunction. We therefore sought to investigate whether ED was associated with a more
generalized form of endothelial dysfunction by measuring hyperemic response to tourni-
quet occlusion utilizing peripheral artery tonometry (PAT). Twenty men (mean age 43,
range 35-57) who presented to urologists for evaluation of ED with no history of coronary,
cerebral or peripheral vascular disease underwent study. No patient was receiving treat-
ment for atherosclerotic vascular disease or associated risk factors. All patients had
penile Doppler evidence of ED. Risk factors defined by laboratory testing and physical
examination at the time of PAT included abnormalities of lipid metabolism (15/20), smok-
ing (20/20), hypertension (12/20) and family history of coronary artery disease (8/20), but
not diabetes. No patient had seen a primary care physician in the preceding 2 years.
Baseline finger PAT was measured in all subjects in the fasting state, supine position,
after acclimation to the room for 30 minutes. Hyperremia was induced for 5 minutes utiliz-
ing tourniquet occlusion and peripheral arterial tone measured continuously upon
release. Select values at 1 & 3 minutes post release were measured. The ratio of base-
line PAT to peak hyperemic response was calculated for each patient. Previous work, cor-
relating PAT with brachial artery ultrasound, has shown a cut-off below 1.4 to be
abnormal. 18/20 patients had abnormal ratios (mean 1.26, range 1.1 to 1.37) consistent
brachiall artery endothelial dysfunction Thus, ED appears to be a part of a larger disorder
of generalized endothelial dysfunction. Given the generalized abnormalities of endothe-
lial function and the high prevalence of risk factors for atherosclerosis, patients present-
ing with ED of vascular origin should be considered for inclusion in primary preventative
strategies.
1066-197 Catheter Sequence Rather Than Catheter Shape 
Determines the Frequency of Cerebral Microemboli 
During Cardiac Catheterization
Devang N. Patel, Stanley J. Chetcuti, Paul M. Grossman, Debabrata Mukherjee, Eric R. 
Bates, University of Texas Health Science Center at San Antonio, San Antonio, TX, 
University of Michigan Medical Center, Ann Arbor, MI
Background
There is small risk of embolic stroke associated with cardiac catheterization. Cerebral
microemboli can be detected by TransCranial Doppler (TCD) as High Intensity Transient
Signals (HITS), and have been shown to correlate with risk of stroke. Objective of our
study was to test the hypothesis that: (1) the frequency HITS during cardiac catheteriza-
tion is related to catheter sequence rather than shape, and (2) is decreased with the use
of guidewire exchanges.
Methods
Transcranial Doppler (Nicolet/EME Companion) was used to continuously interrogate the
left middle cerebral artery of patients during elective cardiac catheterization. Patients
were randomized to:
1. Receive Judkins Left (JL) catheter first vs. Judkins Right (JR) catheter first.
2. Guide wire exchange vs. no guidewire exchange.
Use and timing of the pigtail catheter was left to discretion of the physician.
Results
Seventeen patients were enrolled; however TCD signal was lost in 1 patient during the
study. Pigtail catheter was not used in 3 patients. The number of HITS (Mean ± S.D.)
detected during passage of each catheter is shown in Table 1.
Table 1
Conclusions
Our study suggests that most microemboli are generated by the passage of the initial
catheter, and that they diminish with passage of subsequent catheters. The frequency of
microemboli is not related to catheter shape and is not affected by the use of guidewires.
Catheter Type – JL vs. JR
JL (n=16) JR (n=16) p
2.88 ± 6.67 4.13 ± 6.62 NS
Catheter Type – JL vs. JR vs. Pig
JL (n=13) JR (n=13) Pig (n=13) p
3.08 ± 7.37 4.69 ± 7.25 8.69 ± 8.64 NS
Catheter Sequence – JL and JR
1st (n=16) 2nd (n=16) p
5.25 ± 8.26 1.75 ± 3.80 0.01
Catheter Sequence – JL, JR and Pig
1st (n=13) 2nd (n=13) 3rd (n=13) p
8.85 ± 8.48 5.46 ± 9.28 2.15 ± 4.14 0.05
Guidewire
Yes (n=19) No (n=26) p
5.53 ± 8.88 4.62 ± 6.49 NS
